Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001329746 | SCV001521268 | uncertain significance | Mitral valve prolapse, myxomatous 2 | 2019-02-21 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV003558808 | SCV004278546 | uncertain significance | not provided | 2023-05-24 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DCHS1 protein function. ClinVar contains an entry for this variant (Variation ID: 1028650). This variant has not been reported in the literature in individuals affected with DCHS1-related conditions. This variant is present in population databases (rs371379877, gnomAD 0.006%). This sequence change replaces glutamic acid, which is acidic and polar, with valine, which is neutral and non-polar, at codon 1262 of the DCHS1 protein (p.Glu1262Val). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |